Search

everythinglearnresearchcommunity

for

Search:↓

Combining Nanofat with PRP is a safe and effective treatment for female pattern hair loss.

The modified stem cells with VEGF165 in a special scaffold improved blood vessel growth and wound healing for skin repair.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

The 1927 nm fractional thulium laser effectively treats acne by targeting and improving affected skin areas.

Vitisin A reduces triglycerides better than Cyanidin-3-O-glucoside.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The -866G/A polymorphism in the UCP2 gene is not linked to polycystic ovary syndrome.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

UV light makes skin signs of lack of carotene and vitamin A more visible.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Fahr syndrome causes brain calcification and is managed by treating symptoms and underlying issues.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Patients often overestimate their skin type, affecting sun protection and treatment plans.

PUFA-rich oil improves pet hair quality but may raise triglyceride levels.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

A black-skinned woman was diagnosed with Vogt-Koyanagi-Harada disease and treated with steroids and eye drops.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.